Published in Circ Arrhythm Electrophysiol on June 17, 2010
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation (2015) 2.12
Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab (2011) 1.60
Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol (2013) 1.24
Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc (2014) 1.22
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One (2013) 1.11
Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol (2014) 1.02
Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. Curr Cardiol Rev (2012) 0.98
Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation (2012) 0.97
Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc (2012) 0.95
Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther (2012) 0.94
Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol (2011) 0.92
Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol (2015) 0.87
Pericardial fat is associated with atrial conduction: the Framingham Heart Study. J Am Heart Assoc (2014) 0.84
Evaluation of Electrocardiographic T-peak to T-end Interval in Subjects with Increased Epicardial Fat Tissue Thickness. Arq Bras Cardiol (2015) 0.83
Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation. PLoS One (2013) 0.82
Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. Int J Cardiol (2014) 0.82
Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes (2014) 0.81
Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol (2013) 0.81
Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One (2013) 0.80
Determinants of left atrial appendage volume in stroke patients without chronic atrial fibrillation. PLoS One (2014) 0.79
The association between atrium electromechanical interval and pericardial fat. PLoS One (2014) 0.79
Pattern specification and immune response transcriptional signatures of pericardial and subcutaneous adipose tissue. PLoS One (2011) 0.79
Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation. J Interv Card Electrophysiol (2015) 0.79
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. Am J Physiol Heart Circ Physiol (2015) 0.78
Relation of Pericardial Fat, Intrathoracic Fat, and Abdominal Visceral Fat With Incident Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol (2016) 0.78
Number of P-wave fragmentations on P-SAECG correlates with infiltrated atrial fat. Ann Noninvasive Electrocardiol (2013) 0.78
Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria. Proc Natl Acad Sci U S A (2017) 0.78
Association of intramural fat deposition in the interatrial septum with focal atrial tachyarrhythmias originating near the atrioventricular node. Heart Vessels (2013) 0.77
Anatomical proximity between ganglionated plexi and epicardial adipose tissue in the left atrium: implication for 3D reconstructed epicardial adipose tissue-based ablation. J Interv Card Electrophysiol (2016) 0.77
Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update. J Cardiovasc Pharmacol (2015) 0.77
The Abundance of Epicardial Adipose Tissue Surrounding Left Atrium Is Associated With the Occurrence of Stroke in Patients With Atrial Fibrillation. Medicine (Baltimore) (2016) 0.76
Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram. Cureus (2017) 0.76
Cardiovascular magnetic resonance of total and atrial pericardial adipose tissue: a validation study and development of a 3 dimensional pericardial adipose tissue model. J Cardiovasc Magn Reson (2013) 0.76
Association of epicardial and peri-atrial adiposity with the presence and severity of non-valvular atrial fibrillation. Int J Cardiovasc Imaging (2014) 0.76
Intrinsic Cardiac Autonomic Ganglionated Plexi within Epicardial Fats Modulate the Atrial Substrate Remodeling: Experiences with Atrial Fibrillation Patients Receiving Catheter Ablation. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
Quantification of epicardial fat: Which method can predict significant coronary artery disease? World J Cardiol (2015) 0.75
Interatrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation. Korean J Intern Med (2015) 0.75
Commentary on: Pericardial Fat is Independently Associated with Human Atrial Fibrillation by Al Chekakie et al. J Atr Fibrillation (2010) 0.75
Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias. Cureus (2017) 0.75
Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study. BMC Public Health (2016) 0.75
Excessive interatrial adiposity is associated with left atrial remodeling, augmented contractile performance in asymptomatic population. Echo Res Pract (2016) 0.75
Evaluating the benefits of home-based management of atrial fibrillation: current perspectives. Pragmat Obs Res (2016) 0.75
Factors Associated With Left Atrial Remodeling in the General Population. Circ Cardiovasc Imaging (2017) 0.75
The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects. PLoS One (2016) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. Am J Med (2017) 0.75
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc (2017) 0.75
Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System. Korean Circ J (2017) 0.75
Maximal pericoronary adipose tissue thickness is associated with hypertension in nonobese patients with acute or chronic illness. Korean J Intern Med (2016) 0.75
Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats. J Am Heart Assoc (2017) 0.75
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Human epicardial adipose tissue is a source of inflammatory mediators. Circulation (2003) 6.31
An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci (1963) 6.29
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95
Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab (2003) 4.05
Human epicardial adipose tissue: a review. Am Heart J (2007) 3.74
Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) (2006) 3.69
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med (2005) 3.38
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol (2006) 3.31
Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J (1998) 3.17
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis (2001) 2.66
Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest (2003) 2.48
"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet (2005) 2.24
Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol (1985) (2008) 1.98
Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring) (2009) 1.82
Clinical, electrocardiographic and morphologic features of massive fatty deposits ("lipomatous hypertrophy") in the atrial septum. J Am Coll Cardiol (1993) 1.77
Clinical and morphologic features of lipomatous hypertrophy ("massive fatty deposits") of the interatrial septum. Am J Forensic Med Pathol (1996) 1.76
Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation (2000) 1.74
Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol (2008) 1.73
Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol (2008) 1.72
Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation (2009) 1.65
Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care (2008) 1.62
Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol (2004) 1.60
Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation (1997) 1.58
Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) (2008) 1.56
Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J (2007) 1.42
Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol (1995) 1.36
Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol (2006) 1.33
Lipomatous hypertrophy of the interatrial septum: in vivo diagnosis. Circulation (1982) 1.21
Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des (2007) 1.14
Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol (2006) 1.02
P-wave duration and dispersion in obese subjects. Ann Noninvasive Electrocardiol (2008) 1.00
Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res (2006) 0.97
Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes (Lond) (2006) 0.95
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. Obes Surg (2007) 0.94
Effect of weight loss on P wave dispersion in obese subjects. Obesity (Silver Spring) (2006) 0.92
The intrinsic cardiac nervous system and atrial fibrillation. Curr Opin Cardiol (2006) 0.90
Lipomatous hypertrophy of the interatrial septum presenting as sick sinus syndrome. Int J Cardiol (2006) 0.89
Clinical, laboratory, and transesophageal echocardiographic correlates of interatrial septal thickness: a population-based transesophageal echocardiographic study. J Am Soc Echocardiogr (2005) 0.79
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics (2008) 15.77
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One (2010) 7.48
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47